MARAVAI LIFESCIENCES HOLDINGS, INC.
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a life sciences company providing critical products and services that enable the development of drugs, therapeutics, vaccines, and diagnostics while supporting research on human disease. The company operates through two reportable segments: TriLink and Cygnus,… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What MARAVAI LIFESCIENCES HOLDINGS, INC. does
In the company’s own words
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a life sciences company providing critical products and services that enable the development of drugs, therapeutics, vaccines, and diagnostics while supporting research on human disease. The company operates through two reportable segments: TriLink and Cygnus, which together serve biopharmaceutical companies, emerging biotech firms, life science research organizations, academic institutions, and diagnostics companies globally.
TriLink, representing 64 percent of revenue, provides nucleic acid products and related services including messenger RNA, oligonucleotides, and the company's proprietary CleanCap® mRNA capping technology and ModTail™ poly(A) tail modification technology. The segment also offers synthesis inputs, nucleoside triphosphates, specialty enzymes, and mRNA manufacturing services spanning discovery-scale through commercial-phase production. Cygnus, accounting for 36 percent of revenue, provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays, viral clearance prediction tools, and custom analytical services used to detect process-related impurities during biopharmaceutical production.
The company maintains manufacturing and analytical facilities in San Diego, California; Leland, North Carolina; Sterling, Virginia; and Jupiter, Florida, supporting operations across both segments. As of December 31, 2025, Maravai employed 435 full-time employees globally and serves customers in approximately 60 countries through a combination of direct sales and distributor partnerships.
Maravai's intellectual property strategy centers on protecting core products and services through patents, trademarks, and trade secrets. The company holds numerous granted patents related to CleanCap® technology and MockV® viral clearance prediction tools, with most expiring in 2034 through 2036. The company's website is located at www.maravai.com, with investor relations information available at investors.maravai.com. Maravai operates as a large accelerated filer and is a well-known seasoned issuer under Securities and Exchange Commission regulations.
Company details
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Headquarters
- SAN DIEGO, CA
- Fiscal year end
- December
- CIK
- 1823239
- SIC
- 2834
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns MARAVAI LIFESCIENCES HOLDINGS, INC. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · MARAVAI LIFESCIENCES HOLDINGS, INC.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do MARAVAI LIFESCIENCES HOLDINGS, INC. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of MARAVAI LIFESCIENCES HOLDINGS, INC.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in MARAVAI LIFESCIENCES HOLDINGS, INC.'s last four quarterly filings that the numbers alone won't show?”